|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-04-24 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 14-04-22 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 2023-09-30 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 2017-03-31 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2014-12-31 | |
Haruhisa Inada
BRD | Director/Board Member | - | 2014-04-29 |
Shingo Torii
BRD | Director/Board Member | 73 | 2014-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.36% | -1.99% | -14.67% | -30.35% | 234B | ||
| +0.39% | +0.60% | -43.37% | -55.43% | 40.54B | ||
| +0.09% | +0.11% | -43.60% | -53.29% | 20.52B | ||
| +0.39% | -1.74% | -46.46% | -67.28% | 15.8B | ||
| +1.90% | +0.14% | +5.18% | +37.16% | 10.15B | ||
| +0.89% | +0.87% | -45.49% | -70.88% | 8.56B | ||
| 0.00% | -1.26% | +5.67% | -48.08% | 8.11B | ||
| +1.79% | +3.65% | -40.63% | -64.95% | 6.57B | ||
| +3.03% | -1.38% | -30.71% | -51.87% | 5.16B | ||
| Average | +0.90% | +0.55% | -28.23% | -45.00% | 38.88B | |
| Weighted average by Cap. | -0.02% | -0.84% | -21.56% | -36.68% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















